Tropical Plant Health Initiative Act

Senate Bill

S. 2897

119th Congress

Tropical Plant Health Initiative Act

In Committee

Introduced:Sep 18, 2025

Primary Sponsor

Mazie K. Hirono

Senator

Democratic

HI

Cosponsors

6

Quick Stats

Policy Area

Health

Summary

This bill aims to make it easier for drug companies to test combinations of existing cancer drugs as treatments for pediatric cancers. It would modify certain rules and reporting requirements to encourage these types of clinical trials, which could lead to new treatment options for children with cancer.

Latest Action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

SponsorMazie K. Hirono (D-HI)

Introduced9/18/2025

StatusRead twice and referred to the Committee on Agriculture, Nutrition, and Forestry.

ChamberSenate

Data from Congress.gov

See this page through your district lens

Enter ZIP to personalize representatives and vote context.

Stay on top of this issue

Subscribe for weekly bill and representative updates.

Vote Prediction

Tropical Plant Health Initiative Act

This bill aims to make it easier for drug companies to test combinations of existing cancer drugs as treatments for pediatric cancers. It would modify certain rules and reporting requirements to encourage these types of clinical trials, which could lead to new

Community Breakdown

Pass

0%

Fail

0%

0 predictions

This bill aims to make it easier for drug companies to test combinations of existing cancer drugs as treatments for pediatric cancers. It would modify certain rules and reporting requirements to encourage these types of clinical trials, which could lead to new treatment options for children with cancer.

Bill Number: 2897
Sponsor: Mazie K. Hirono (D-HI)
Introduced: 9/18/2025
Status: Read twice and referred to the Committee on Agriculture, Nutrition, and Forestry.
Policy Area: Health

Data from Congress.gov

AI-generated summary

Fact Sheet

Title: Tropical Plant Health Initiative Act
Bill Number: 2897
Sponsor: Mazie K. Hirono (D-HI)
Status: Read twice and referred to the Committee on Agriculture, Nutrition, and Forestry.
Introduced: 9/18/2025
Summary: This bill aims to make it easier for drug companies to test combinations of existing cancer drugs as treatments for pediatric cancers. It would modify certain rules and reporting requirements to encourage these types of clinical trials, which could lead to new treatment options for children with can

Data from Congress.gov

AI Summary

Plain-English explanation of this bill

This bill aims to make it easier for drug companies to test combinations of existing cancer drugs as treatments for pediatric cancers. It would modify certain rules and reporting requirements to encourage these types of clinical trials, which could lead to new treatment options for children with cancer.

Last updated: 12/29/2025

Official Summary

Congressional Research Service summary

Give Kids a Chance Act of 2023 This bill authorizes certain targeted clinical trials involving combinations of drugs to treat pediatric cancer. Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations so as to authorize investigations of new drugs that are used in combination with active ingredients that have already been approved and that (1) have been determined to be the standard of care for treating a pediatric cancer, or (2) have been approved to treat an adult cancer and are directed at molecular targets for pediatric cancer. The Food and Drug Administration must issue guidance and report on the bill's implementation. The Government Accountability Office must report on the effectiveness of the bill's changes with respect to the development of pediatric cancer drugs.

Key Points

Main provisions of the bill

Authorizes clinical trials testing combinations of existing drugs to treat pediatric cancers
Modifies rules to allow trials of drug combinations where one drug is already approved to treat an adult cancer
Requires the FDA to issue guidance and report on the implementation of these changes
Requires the GAO to report on the effectiveness of these changes in developing new pediatric cancer treatments

How This Impacts Americans

Potential effects on citizens and communities

If enacted, this bill could benefit children with cancer and their families by potentially leading to new treatment options. It would also affect pharmaceutical companies by making it easier for them to pursue clinical trials of drug combinations for pediatric cancers, which are a smaller market than adult cancers.

Policy Areas

Primary Policy Area

Health

Scope & Jurisdiction

Jurisdiction Level

federal

Congressional Session

119th Congress

Citation Reference

2897, 119th Congress (2025). "Tropical Plant Health Initiative Act". Source: Voter's Right Platform. https://votersright.org/bills/118-s-2897

Public Opinions

Community submissions related to this bill.

Share your opinion

No public opinions yet. Be the first to submit one for this bill.

Related Bills in Health

HR 3021

Empowering Patient Choice of Medical Care Act

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means

HR 2111

To amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations.

Referred to the House Committee on Energy and Commerce.

HR 2884

Anti-Racism in Public Health Act of 2025

Referred to the House Committee on Energy and Commerce.

S 1406

SOAR Act of 2025

Read twice and referred to the Committee on Finance.